CORT — Corcept Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Corcept Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	276	441	224	432	368
Net Total Accounts Receivable
Net Total Receivables	19.9	26.2	27.6	31.1	41.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	307	479	266	499	459
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.5	4.18	1.52	1.78	0.315
Long Term Investments
Other Long Term Assets
Total Assets	412	572	424	583	622
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	38.8	47.5	47.5	72.5	105
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	41.1	48.4	48	81.6	115
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	371	523	376	502	507
Total Liabilities & Shareholders' Equity	412	572	424	583	622
Total Common Shares Outstanding